posted on Feb 17 2009
Dear PKUers,
Sino-American Biomedical and Pharmaceutical Professionals Association (SABPA)
Best regards,
PUAASC
--------------------------------------------------------------
4th Annual Biomedical Forum
Date: March 28, 2009 (Saturday)
Location: McDonald Douglass Auditorium, UC Irvine
Registration (Lunch included): $30 for pre-registration (before March 14), $15 for students and post-docs, $40 for onsite registration
Online Registration: http://www.sabpa.org/web/news_details.php?ID=157
Program
Mitchell Brin, M.D.
Senior Vice President, Global Drug Development & Chief Scientific Officer, Allergan, LLC. & Clinical Professor of Neurology, University of California,
“Discovery And Development of Botoxâ€
David Ke, M.D.
Executive Scientific Director, Amgen, Inc.
“Transforming Basic Science To Drug Discovery: The Story Of Sclerosteosis And Development Of Anti-Sclerostin Monoclonal Antibodyâ€
James Shen Ph.D.
Import Compliance Officer, FDA
“Requirements Of Laws And Regulations Enforced By FDA Concerning Medical And Pharmaceutical Productsâ€
Stan Rowe
Chief Scientific Officer, Corporate Vice President, Edwards Lifesciences LLC
“Practical Innovations in Cardiac Disease Managementâ€
Peter Chen, Ph.D.
President, Center for Innovation and Strategic Collaboration, St. Jude Medical, Inc.
“Innovations in Cardiac Rhythm Management and Neuromodulation Devicesâ€
Rob Michiels
Chief Operating Officer, CoreValve Inc.
“Transformation in Heart Valve Replacementâ€
Sofie Qiao, Ph.D.
Founder, Senior VP,Director of Chinese Operations, Lead Therapeutics, Inc
"The Long LEAD to Venture Funding"
Daren Chen
Hillcrest Venture Partners, A New Lifescience Venture Fund.
“Investment Criteria in the New Global Economyâ€
Yuwen Liu
General Manager, Biobay, Suzhou Industrial Park.
“Biomedical Technology Investment and Entrepreneurs in Suzhou, Chinaâ€